Today: 11 November 2025
Subscribe
Browse Category

Healthcare News 8 July 2025 - 19 August 2025

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Breakthroughs, Pharma Power Moves & Health Shocks: News Roundup (Aug 18–19, 2025)

Biotech Sector – Big Deals, Funding, and FDA Drama Pharma & Drug Development – Approvals, Showdowns, and Safety Signals Medical & Clinical Updates – Guidelines and Safety Notices Public Health & Policy – Vaccine Rift, Medicare Cuts, and Wellness Initiatives Sources: Key news and expert quotes were gathered from Fierce Biotech fiercebiotech.com fiercebiotech.com, Fierce Pharma fiercepharma.com fiercepharma.com, Fierce Healthcare fiercehealthcare.com fiercehealthcare.com, STAT News statnews.com statnews.com, the Florida Phoenix floridaphoenix.com floridaphoenix.com, CIDRAP cidrap.umn.edu cidrap.umn.edu, and other authoritative sources as cited above. Each development is linked to its original reporting for further reading. The roundup covers events and announcements from August 18–19,
19 August 2025
 ·  ·  ·  ·  ·  · 
Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

For the period August 16–17, 2025, the biotech, pharma, medical, and health sectors saw a range of significant developments worldwide. Below is a comprehensive roundup of top stories categorized by theme, complete with expert insights and source links: Clinical Trial Results & Study Readouts Drug & Device Approvals Mergers, Acquisitions & Partnerships Public Health Alerts Research & Medical Breakthroughs Healthcare Policy & Industry Trends Each news item above includes direct source references for verification. This roundup spans clinical trial outcomes, drug approvals, industry deals, public health alerts, research breakthroughs, and policy updates from around the globe during August 16–17, 2025,
17 August 2025
 ·  ·  ·  · 
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Researchers in China unveiled a hydrogel-based “smart” wound dressing that speeds diabetic ulcer healing, with a single application achieving about 90% wound closure in 12 days by delivering microRNA-loaded vesicles that suppress the vessel-growth inhibitor TSP-1. A Swedish study published August 8 identified 87 DNA methylation sites in blood from 752 newly diagnosed diabetics followed for seven years, creating a score that predicted cardiovascular outcomes with 96% accuracy for identifying low-risk patients. A natural compound in maple tree syrup, epicatechin gallate (ECG), blocked Streptococcus mutans biofilm formation in lab tests, suggesting potential as a safe plaque-preventing agent in mouthwash or
10 August 2025
 ·  ·  ·  · 
Revolutionary Medical Breakthroughs of July 2025: Life-Changing Drugs, Diagnostic Wonders & Public Health Milestones

Revolutionary Medical Breakthroughs of July 2025: Life-Changing Drugs, Diagnostic Wonders & Public Health Milestones

On July 2, 2025, the FDA granted accelerated approval to linvoseltamab (Lynozyfic), a BCMA-targeting bispecific antibody, for adults with heavily pretreated relapsed/refractory multiple myeloma, after trials showed a 70% response rate. Also on July 2, 2025, the FDA approved sunvozertinib (Zegfrovy) as the first targeted oral therapy for advanced NSCLC with EGFR exon 20 insertion mutations following chemotherapy. In July 2025, the FDA granted Breakthrough Therapy designation to trastuzumab deruxtecan (T-DXd) plus pertuzumab for HER2-positive metastatic breast cancer. Relutrigine (PRAX-562) received FDA Breakthrough Therapy designation for two rare pediatric epileptic encephalopathies (SCN2A and SCN8A) after a Phase 2 study showed
22 July 2025
 ·  ·  ·  · 
Ambient Listening Revolution: How Nuance’s Always‑On AI is Transforming Healthcare, Homes, and More

Ambient Listening Revolution: How Nuance’s Always‑On AI is Transforming Healthcare, Homes, and More

Nuance Communications, acquired by Microsoft in 2022 for about $19.7 billion, pioneered ambient clinical intelligence and Dragon Medical used by more than 550,000 physicians. In 2020 Nuance launched Dragon Ambient eXperience (DAX) to securely capture doctor‑patient conversations and automatically generate clinical documentation. In March 2023 Nuance announced DAX Express, the first fully AI‑automated clinical documentation app combining ambient AI with OpenAI’s GPT‑4. By mid‑2023 DAX Express was being integrated into Epic’s EHR software as a “co‑pilot” for clinicians. In 2025 Microsoft unveiled Dragon Copilot, a unified voice AI that merges Dragon Medical One with DAX ambient listening and new GPT‑based
20 July 2025
 ·  ·  ·  ·  · 
The State of AI: Agentic Revolution, Healthcare Breakthroughs & Global Governance / Updated: 2025, July 8th, 12:00 CET

The State of AI: Agentic Revolution, Healthcare Breakthroughs & Global Governance / Updated: 2025, July 8th, 12:00 CET

In the United States, more than 777 FDA-cleared AI devices are in clinical use for medical imaging, slashing scan times and flagging urgent cases. Microsoft’s MAI-DxO AI system achieves up to 85.5% diagnostic accuracy, vastly outperforming doctors at about 20%. Chugai Pharmaceutical and Gero announced a $1B+ collaboration to discover targets for age-related diseases using Gero’s AI platform. Meta Platforms recruited Apple’s Ruoming Pang, head of foundational models, in a multi‑million‑dollar deal, while Meta maintains over $55 billion in cash reserves for AI investments. Ford Chairman Jim Farley warned that AI could eliminate up to half of white-collar jobs, a
8 July 2025
 ·  ·  ·  · 
1 2 3
Go toTop